Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMUX Immunic, Inc.

盘后交易 11-21 19:59:27 EST

1.11

+0.04

+3.74%

盘后1.11

+0.00-0.06%

17:50 EST

最高1.13	最低1.05	成交量46.69万
今开1.08	昨收1.07	日振幅7.01%
总市值9,999万	流通市值5,851万	总股本9,008万
成交额50.74万	换手率0.89%	流通股本5,271万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMUX","market":"US","secType":"STK","nameCN":"Immunic, Inc.","latestPrice":1.11,"timestamp":1732222800000,"preClose":1.07,"halted":0,"volume":466882,"hourTrading":{"tag":"盘后","latestPrice":1.1093,"preClose":1.11,"latestTime":"17:50 EST","volume":240,"amount":264.810312,"timestamp":1732229450807},"delay":0,"floatShares":52709465,"shares":90079016,"eps":-1.124851,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.04,"latestTime":"11-21 19:59:27 EST","open":1.08,"high":1.125,"low":1.05,"amount":507386.30122180004,"amplitude":0.070093,"askPrice":1.13,"askSize":50,"bidPrice":1.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.124851,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732237200000},"adr":0,"listingDate":1397707200000,"adjPreClose":1.07,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.0801,"preClose":1.07,"latestTime":"09:29 EST","volume":3178,"amount":3425.2474466,"timestamp":1732199358178},"postHourTrading":{"tag":"盘后","latestPrice":1.1093,"preClose":1.11,"latestTime":"17:50 EST","volume":240,"amount":264.810312,"timestamp":1732229450807},"volumeRatio":0.634934,"impliedVol":0.2853,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/IMUX/tweets","defaultTab":"tweets","newsList":[{"id":"2485308440","title":"Immunic, Inc.盘中异动 临近收盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485308440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485308440?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:30","pubTimestamp":1732221007,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时30分，Immunic, Inc.股票出现异动，股价大幅拉升5.14%。截至发稿，该股报1.13美元/股，成交量37.2466万股，换手率0.41%，振幅6.54%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122043007971a7f3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122043007971a7f3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2484051017","title":"Immunic, Inc.2024财年第三财季实现净利润-24.37百万美元，同比减少7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484051017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484051017?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:00","pubTimestamp":1731772818,"startTime":"0","endTime":"0","summary":"11月17日，Immunic, Inc.公布财报，公告显示公司2024财年第三财季净利润为-24.37百万美元，同比减少7.03%；其中营业收入为0.00美元，每股基本收益为-0.24美元。从资产负债表来看，Immunic, Inc.总负债23.54百万美元，其中短期债务713000.00美元，资产负债比为2.76，流动比率为2.71。机构评级：截至2024年11月17日，当前有6家机构对Immunic, Inc.目标价做出预测，其中目标均价为13.25美元，其中最低目标价为5.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000042a23e04d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000042a23e04d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX"],"gpt_icon":0},{"id":"2483838967","title":"Immunic, Inc.盘中异动 早盘股价大跌5.22%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483838967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483838967?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:43","pubTimestamp":1731512618,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时43分，Immunic, Inc.股票出现波动，股价急速下挫5.22%。截至发稿，该股报1.09美元/股，成交量24.9888万股，换手率0.28%，振幅7.83%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113234338a2347dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113234338a2347dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2482401768","title":"Immunic, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482401768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482401768?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:42","pubTimestamp":1731357737,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时42分，Immunic, Inc.股票出现波动，股价大幅上涨5.08%。截至发稿，该股报1.24美元/股，成交量211.288万股，换手率2.35%，振幅6.78%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112044218971a5cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112044218971a5cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2481985316","title":"Immunic, Inc.盘中异动 早盘股价大涨5.01%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985316?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903498,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Immunic, Inc.股票出现异动，股价大幅拉升5.01%。截至发稿，该股报1.25美元/股，成交量5.9593万股，换手率0.07%，振幅0.00%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223139971a4baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223139971a4baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2481160000","title":"Immunic Inc    预计每股亏损 22 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481160000","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481160000?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903443,"startTime":"0","endTime":"0","summary":"   * Immunic公司   将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于纽约的公司预计将实现750万美元的营收。* LSEG 分析师对 Immunic Inc 的平均预期是每股亏损 22 美分。* 华尔街对 Immunic Inc 的 12 个月目标价中位数为 10.25 美元，高于其最新收盘价 1.19 美元。11月6日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Immunic Inc    预计每股亏损 22 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMUX"],"gpt_icon":0},{"id":"2478935081","title":"Immunic, Inc.盘中异动 早盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478935081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478935081?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:30","pubTimestamp":1729863059,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时30分，Immunic, Inc.股票出现异动，股价快速上涨5.07%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213103a1ea7fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213103a1ea7fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2477653403","title":"Immunic, Inc.盘中异动 早盘大幅下挫6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477653403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477653403?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:57","pubTimestamp":1729781842,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时57分，Immunic, Inc.股票出现异动，股价急速下挫6.29%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422572298e3e47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422572298e3e47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2477352553","title":"BUZZ--美国股票走势-洛克希德马丁公司、通用汽车公司、菲利普莫里斯国际公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352553?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:53","pubTimestamp":1729612383,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月22日 - 周二美国股指下挫，原因是国债收益率上升影响了对利率敏感的行业，同时投资者通过评估收益来评估美国公司的健康状况。美东时间11:32，道琼斯工业平均指数  下跌0.2%，报42860.24点。标普500指数  下跌0.22%，报5840.9点；纳斯达克综合指数  下跌0.08%，报18524.375点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHW","SQQQ","FCX","FSLR","QLD",".IXIC","DHR","MCO","NUE","ZETA",".SPX","CSIQ","CAKE","IPAR","PII","AOS","MMM","MRCC","CDE","UDOW","TXN","PTON","IPG","CRVS","NSC","RTX","CORZ",".DJI","PCAR","KMB","MGRX","LMT","ZION","DJX","MNQmain","DDM","ASPN","GPC","PSQ","LEGN","WRB","SGMO","TQQQ","DGX","SDOW","IMUX"],"gpt_icon":1},{"id":"2477330100","title":"Immunic, Inc.盘中异动 早盘大幅拉升11.57%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477330100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477330100?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603894,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，Immunic, Inc.股票出现波动，股价快速上涨11.57%。截至发稿，该股报1.73美元/股，成交量612.546万股，换手率6.80%，振幅1.94%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131349f56b94c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131349f56b94c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2477339619","title":"BUZZ--美国股票走势-3M、威瑞森通信、金佰利克拉克","url":"https://stock-news.laohu8.com/highlight/detail?id=2477339619","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477339619?lang=zh_cn&edition=full","pubTime":"2024-10-22 20:23","pubTimestamp":1729599818,"startTime":"0","endTime":"0","summary":"nL4N3LY0VV  ** Immunic Inc IMUX.O：盘前上涨18.1% BUZZ - 因多发性硬化症药物的中期后期数据而跳涨 nL4N3LY0XZ  ** Wolfspeed Inc WOLF.N：盘前下跌2.9% BUZZ - 因有报道称采埃孚退出德国芯片厂合作而下跌 nL4N3LY0YF (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nL4S3LY13S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","KMB","ZETA","BK4585","LU1066053197.SGD","PII","BK4190","LMT","MLI","MRCC","SG9999001440.SGD","LU1861215975.USD","IE00BMPRXN33.USD","LU2237443978.SGD","LU0130103400.USD","MMM","IMUX","DHR","SHW","GRI","LU2355687059.USD","WOLF","01548","IE00BFMHRM44.USD","GNPX","LU0130102774.USD","CRVS","AMN","CDE","LU2211814178.USD","LU1621768206.USD","BK4568","ENSC","LU0122379950.USD","LCID","LU1791710582.SGD","BK4504","LU0006061336.USD","HL","LU1804176565.USD","LU0130517989.USD","LU0130518102.USD","SNSE","GPC","HK0000306685.HKD","BK4515","GM","VZ","LU0289739343.SGD","LEGN"],"gpt_icon":1},{"id":"2477894387","title":"BUZZ-多发性硬化症药物后期中期数据公布后，Immunic 跃居榜首","url":"https://stock-news.laohu8.com/highlight/detail?id=2477894387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477894387?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:19","pubTimestamp":1729595964,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月22日 - ** 药物开发商Immunic  股价盘前上涨20%至1.86美元 ** 该公司称，一个独立的数据监测委员会建议继续进行一种试验性多发性硬化症药物的后期试验，不做任何改动** 这种名为 vidofludimus calcium 的药物正在多发性硬化症患者中进行试验，多发性硬化症是一种影响中枢神经系统的慢性自身免疫性疾病。** 委员会建议在进行中期分析--IMUX--后，该试验并非徒劳无益，应按计划继续进行。 ** 公司预计这项研究将于 2026 年完成** 截至上次收盘，股价累计上涨 3.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2476481248","title":"Immunic, Inc.盘中异动 下午盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476481248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476481248?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:10","pubTimestamp":1729188649,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时10分，Immunic, Inc.股票出现异动，股价快速上涨5.19%。截至发稿，该股报1.62美元/股，成交量27.4762万股，换手率0.31%，振幅8.12%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018021050ab6ae0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018021050ab6ae0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2475997780","title":"Immunic, Inc.盘中异动 早盘急速上涨5.13%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475997780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475997780?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:33","pubTimestamp":1729085593,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时33分，Immunic, Inc.股票出现异动，股价急速拉升5.13%。截至发稿，该股报1.58美元/股，成交量3.8337万股，换手率0.04%，振幅4.67%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213313971a09f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213313971a09f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2475364209","title":"Immunic, Inc.盘中异动 股价大涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475364209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475364209?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:31","pubTimestamp":1728912710,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时31分，Immunic, Inc.股票出现波动，股价快速上涨5.00%。截至发稿，该股报1.47美元/股，成交量1.0322万股，换手率0.01%，振幅0.97%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213151971a014e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213151971a014e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2474453015","title":"Immunic, Inc.盘中异动 早盘股价大涨7.14%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474453015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474453015?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:14","pubTimestamp":1728659657,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时14分，Immunic, Inc.股票出现波动，股价快速上涨7.14%。截至发稿，该股报1.50美元/股，成交量65.8106万股，换手率0.73%，振幅8.58%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101123141898e3be94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101123141898e3be94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2474203707","title":"Immunic, Inc.盘中异动 下午盘股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474203707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474203707?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:18","pubTimestamp":1728501524,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时18分，Immunic, Inc.股票出现异动，股价急速下挫5.13%。截至发稿，该股报1.48美元/股，成交量33.2019万股，换手率0.37%，振幅6.40%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100318449719f510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100318449719f510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2473487638","title":"Immunic, Inc.盘中异动 下午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473487638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473487638?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:30","pubTimestamp":1728325851,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时30分，Immunic, Inc.股票出现波动，股价大幅下挫5.19%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008023051a1deb3f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008023051a1deb3f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2471038118","title":"Immunic, Inc.盘中异动 急速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471038118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471038118?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:14","pubTimestamp":1727705650,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日22时14分，Immunic, Inc.股票出现异动，股价快速拉升5.15%。截至发稿，该股报1.63美元/股，成交量5.6494万股，换手率0.06%，振幅5.16%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930221411a1ddb642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930221411a1ddb642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2470444168","title":"Immunic, Inc.盘中异动 临近收盘快速下跌5.00%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470444168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470444168?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:49","pubTimestamp":1727207396,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时49分，Immunic, Inc.股票出现波动，股价急速下跌5.00%。截至发稿，该股报1.52美元/股，成交量64.7104万股，换手率0.72%，振幅7.50%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925034956a1dc40c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925034956a1dc40c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.imux.com","stockEarnings":[{"period":"1week","weight":-0.0855},{"period":"1month","weight":-0.3097},{"period":"3month","weight":-0.2961},{"period":"6month","weight":-0.144},{"period":"1year","weight":0.0047},{"period":"ytd","weight":-0.2867}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunic, Inc.通过收购VitaGen公司的资产和业务，作为一个加利福尼亚州的公司于2003年5月23日开始运营，并于2003年6月更名为Vital生命治疗有限公司。2004年1月，公司再次在特拉华州注册成立。公司是一家生物治疗公司，致力于开发基于细胞的急性肝功能衰竭的治疗。候选产品目前在三期临床试验中，ELAD系统（或ELAD）是一个体外生物人工肝治疗，目的是在病人移植之前让病人自己的肝脏再生一个健康的状态或稳定的肝脏。自成立以来，它已经基本上倾注了全部的努力至产品开发、临床试验和试生产，还没有意识到收入来自计划主营业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.058839},{"month":2,"riseRate":0.3,"avgChangeRate":-0.011826},{"month":3,"riseRate":0.3,"avgChangeRate":-0.04127},{"month":4,"riseRate":0.3,"avgChangeRate":0.053504},{"month":5,"riseRate":0.1,"avgChangeRate":-0.071878},{"month":6,"riseRate":0.545455,"avgChangeRate":0.141547},{"month":7,"riseRate":0.545455,"avgChangeRate":0.02756},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.034318},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.086965},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.027926},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.006801},{"month":12,"riseRate":0.7,"avgChangeRate":0.069641}],"exchange":"NASDAQ","name":"Immunic, Inc.","nameEN":"Immunic, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunic, Inc.(IMUX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunic, Inc.,IMUX,Immunic, Inc.股票,Immunic, Inc.股票老虎,Immunic, Inc.股票老虎国际,Immunic, Inc.行情,Immunic, Inc.股票行情,Immunic, Inc.股价,Immunic, Inc.股市,Immunic, Inc.股票价格,Immunic, Inc.股票交易,Immunic, Inc.股票购买,Immunic, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunic, Inc.(IMUX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}